Singapore markets open in 5 hours 50 minutes
Straits Times Index
3,116.31 -49.19 (-1.55%) S&P 500
3,722.14 +74.85 (+2.05%) Dow
29,707.87 +572.88 (+1.97%) Nasdaq
11,053.22 +223.71 (+2.07%) BTC-USD
19,556.34 +423.05 (+2.21%) CMC Crypto 200
445.87 +17.08 (+3.98%)
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:10PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.51B |
| Enterprise value | 1.17B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.20 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.26 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.50 |
| 52-week change 3 | -58.43% |
| S&P500 52-week change 3 | -16.34% |
| 52-week high 3 | 27.96 |
| 52-week low 3 | 6.18 |
| 50-day moving average 3 | 11.50 |
| 200-day moving average 3 | 13.83 |
Share statistics
| Avg vol (3-month) 3 | 2.52M |
| Avg vol (10-day) 3 | 2.3M |
| Shares outstanding 5 | 157.8M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 128.12M |
| % held by insiders 1 | 0.61% |
| % held by institutions 1 | 106.86% |
| Shares short (30 Aug 2022) 4 | 19.65M |
| Short ratio (30 Aug 2022) 4 | 8.31 |
| Short % of float (30 Aug 2022) 4 | 13.09% |
| Short % of shares outstanding (30 Aug 2022) 4 | 12.45% |
| Shares short (prior month 28 Jul 2022) 4 | 19.42M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 25 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -32.21% |
| Return on equity (ttm) | -61.85% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -370.74M |
| Net income avi to common (ttm) | -376.41M |
| Diluted EPS (ttm) | -2.30 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 424.46M |
| Total cash per share (mrq) | 2.69 |
| Total debt (mrq) | 80.48M |
| Total debt/equity (mrq) | 17.03 |
| Current ratio (mrq) | 6.72 |
| Book value per share (mrq) | 2.99 |
Cash flow statement
| Operating cash flow (ttm) | -262.98M |
| Levered free cash flow (ttm) | -162.45M |
© 2022 Yahoo. All rights reserved.
